Paige.AI's prostate cancer detection tech to be offered by Philips | Leo Pharma to develop needle-free drug delivery system with Portal | Funding round brings in $50M for Akoya
Startup Paige.AI's Paige Prostate cancer detection technology will be offered by Philips to European pathology laboratories next year. The AI-based module was granted FDA breakthrough device status earlier this year.
The Future of Risk Management in Medical Device New eBook: A comprehensive guide to moving from corrective to predictive risk management. Learn how to improve risk management - regardless of PLM maturity, and how to leverage machine learning and advanced analytics to analyze risk and quality data
Leo Pharma agreed to work with Portal Instruments to develop a needle-free jet injector platform for drug delivery. Under the terms of the deal, Portal's system will be used in combination with Leo's investigational and approved medicines.
A funding round has raised $50 million for Akoya Biosciences, which intends to use the proceeds to support the development and commercialization of its Codex and Phenoptics spatial omics platforms.
Orthofix has named Kevin Kenny as the president of its global spine business. Kenny was formerly a chief operating officer of Cardiovascular Systems and vice president of US sales at Medtronic Spine and Biologics.
4,800+ Medical Device Companies Adopt RAMS EMERGO by UL's Regulatory Affairs Management Suite (RAMS), a digital medical device RA/QA management platform, has established itself as manufacturers' go-to resource for regulatory intelligence. Registration and premium services are free for a limited time.
Swedish and Danish researchers found that a deep learning-based algorithm quantifying PET/CT measurements of total prostate lesion uptake and abnormal voxel volume relative to total prostate volume -- but not age, Gleason score and prostate-specific antigen levels -- significantly predicted overall survival among patients with prostate cancer. The findings were published in Clinical Physiology and Functional Imaging.
A micro-implant that sends electrosignals from deep within the spine is being developed by University of Alberta researchers to help restore movement in patients with spinal cord injuries.
A study to be published in Theranostics and based on about 26,000 optical tomography images from colorectal tissue samples found that an OCT-based imaging technique paired with deep learning had 100% accuracy in detecting tumors in real time, compared with pathology reports. Researchers also found that the technique had 100% sensitivity and 99.7% specificity in making colorectal cancer diagnoses, compared with using traditional histology.
The voluntary recall of some Medtronic SynchroMed II implantable drug infusion pumps was categorized as a Class I recall by the FDA. The devices were recalled because of a foreign particle that interfered with the gear rotation of the pump, which could cause the device to stall.
Vicarious Surgical's miniaturized surgical robot received breakthrough device status from the FDA. The device enables single micro-incision surgeries, according to Vicarious.
Roche's cobas vivoDx MRSA diagnostic test has received FDA approval for the detection of methicillin-resistant Staphylococcus aureus bacterial colonization. The test can generate results from nasal swab samples within five hours.
The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.
